269 related articles for article (PubMed ID: 15827818)
1. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
[TBL] [Abstract][Full Text] [Related]
2. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
[TBL] [Abstract][Full Text] [Related]
3. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
4. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
[TBL] [Abstract][Full Text] [Related]
7. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
8. [Detection of micrometastases in axillary lymph nodes of node-negative breast cancer patients and its clinical significance].
Wu J; Yu Z; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):289-91. PubMed ID: 9387324
[TBL] [Abstract][Full Text] [Related]
9. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma.
Bleiweiss IJ; Nagi CS; Jaffer S
J Clin Oncol; 2006 May; 24(13):2013-8. PubMed ID: 16606970
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.
King TA; Ganaraj A; Fey JV; Tan LK; Hudis C; Norton L; Cody HS; Borgen PI
Cancer; 2004 Sep; 101(5):926-33. PubMed ID: 15329899
[TBL] [Abstract][Full Text] [Related]
11. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.
Mullenix PS; Brown TA; Meyers MO; Giles LR; Sigurdson ER; Boraas MC; Hoffman JP; Eisenberg BL; Torosian MH
Am J Surg; 2005 May; 189(5):606-9; discussion 609. PubMed ID: 15862505
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer.
Choi YJ; Yun HR; Yoo KE; Kim JH; Nam SJ; Choi YL; Ko YH; Kim BT; Yang JH
Jpn J Clin Oncol; 2006 Aug; 36(8):489-93. PubMed ID: 16790449
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer.
Lim SJ; Feig BW; Wang H; Hunt KK; Rodriguez-Bigas MA; Skibber JM; Ellis V; Cleary K; Chang GJ
Ann Surg Oncol; 2008 Jan; 15(1):46-51. PubMed ID: 17985187
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
[TBL] [Abstract][Full Text] [Related]
16. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin staining for intraoperative evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma.
Weinberg ES; Dickson D; White L; Ahmad N; Patel J; Hakam A; Nicosia S; Dupont E; Furman B; Centeno B; Cox C
Am J Surg; 2004 Oct; 188(4):419-22. PubMed ID: 15474439
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer pseudometastasis in a sentinel lymph node with cytokeratin-positive debris.
Rao RS; Taylor J; Palmer J; Jennings WC
Breast J; 2005; 11(2):134-7. PubMed ID: 15730460
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C
Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
